Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-Label Trial of Patients With Ulcerative Colitis
Keywords: نمایندگان مجلس; PROgECT; Transcriptomics; Gene Signature; Prediction of Response; AUCROC; area under the receiver operating characteristic curve; CI; confidence interval; IBD; inflammatory bowel disease; MPS; molecular prediction signature; UC; ulcerative colitis;